Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-007032
Filing Date
2022-06-30
Accepted
2022-06-30 15:30:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27515
2 filename2.txt TEXT-EXTRACT 1154
  Complete submission text file 0000000000-22-007032.txt   39883
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filed for) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)